Background. Prostate-specific antigen (PSA) is secreted exclusively by prostatic epithelial
cells, and its serum concentration is increased in men with prostatic disease, including cancer. …

To compare the efficacy of digital rectal examination and serum prostate specific antigen (PSA)
in the early detection of prostate cancer, we conducted a prospective clinical trial at 6 …

The vast majority of coding variants are rare, and assessment of the contribution of rare
variants to complex traits is hampered by low statistical power and limited functional data. …

Context.—The percentage of free prostate-specific antigen (PSA) in serum has been shown
to enhance the specificity of PSA testing for prostate cancer detection, but earlier studies …

Objective. —To determine whether prostate-specific antigen (PSA)—based screening alters
the proportion of organ-confined prostate cancers detected. Design. —A prospective, …

Prostate cancer is the most prevalent noncutaneous cancer in males in developed regions
1 , with African American men having among the highest worldwide incidence and mortality …

Purpose : We updated a long-term cancer control outcome in a large anatomical radical
retropubic prostatectomy (RRP) series. We also evaluated the perioperative parameters that …

Objective. —To determine the detection rate of prostate cancer in a screening population of
men with prostate-specific antigen (PSA) concentrations of 2.6 to 4.0 ng/mL and a benign …

Objective. —To evaluate measurement of percentage of free prostate-specific antigen (PSA)
in serum to improve the specificity of prostate cancer screening in men with serum PSA …

Purpose : We update results in a series of consecutive patients treated with anatomic
radical retropubic prostatectomy regarding recovery of erections, urinary continence and …